Drugs / Mg sulphate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02920905 | Nov 2015 → Apr 2017 | — | Assiut University | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT04769440 Comparator | Mar 2021 → Feb 2022 | — | Ain Shams University | Completed | No outcome recorded |
| — | NCT05632159 Comparator | Nov 2022 → Feb 2023 | — | Beni-Suef University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mg sulphate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02920905 ↗ |
| Route | Intravenous | “mgso4 infusion will start 15 minutes after intubation , 30 mg/kg LBW of 10%mgso4 in 100 ml normal saline I.V ,over 30 minutes followed by 10 mg/kg LBW for 90 minutes” NCT04769440 ↗ |